Cite
GSH‐Responsive Metal–Organic Framework for Intratumoral Release of NO and IDO Inhibitor to Enhance Antitumor Immunotherapy.
MLA
Du, Lihua, et al. “GSH‐Responsive Metal–Organic Framework for Intratumoral Release of NO and IDO Inhibitor to Enhance Antitumor Immunotherapy.” Small, vol. 18, Apr. 2022, pp. 1–12. EBSCOhost, https://doi.org/10.1002/smll.202107732.
APA
Du, L., He, H., Xiao, Z., Xiao, H., An, Y., Zhong, H., Lin, M., Meng, X., Han, S., & Shuai, X. (2022). GSH‐Responsive Metal–Organic Framework for Intratumoral Release of NO and IDO Inhibitor to Enhance Antitumor Immunotherapy. Small, 18, 1–12. https://doi.org/10.1002/smll.202107732
Chicago
Du, Lihua, Haozhe He, Zecong Xiao, Hong Xiao, Yongcheng An, Huihai Zhong, Minzhao Lin, Xiaochun Meng, Shisong Han, and Xintao Shuai. 2022. “GSH‐Responsive Metal–Organic Framework for Intratumoral Release of NO and IDO Inhibitor to Enhance Antitumor Immunotherapy.” Small 18 (April): 1–12. doi:10.1002/smll.202107732.